Urine test reveals hidden chemical signature of muscle injuries in elite footballers

For decades, the training grounds of professional football have been monitored through external metrics: kilometers covered, sprints completed, heart rates logged. But a team of researchers working with FC Barcelona’s medical department has now shown that a player’s own urine may tell a far more intimate story about what is happening inside damaged muscle fibers. In a study published in the journal Metabolomics, scientists analyzed 287 first-morning urine samples collected from 121 elite male football players across two consecutive seasons, and identified a reproducible chemical fingerprint that distinguishes players suffering muscle injuries from their healthy teammates. The work, led by Guillermo Quintás of the Leitat Technological Center together with FC Barcelona physicians including Gil Rodas and Ricard Pruna, offers a glimpse of a future in which a simple urine sample could complement GPS trackers and MRI scans in the high-stakes business of keeping athletes on the pitch.

The scale of the problem the researchers set out to address is substantial. Muscle injuries remain one of the leading causes of time lost from training and competition in professional football, and the biological response to a given training load is highly individual, shaped by a complex web of metabolic, inflammatory, and recovery processes. Current monitoring strategies rely predominantly on external load metrics derived from electronic performance tracking systems, which the authors argue do not fully capture the individual physiological stress and biological cost of training. Metabolomics, the systematic measurement of small molecules that represent the final products of cellular regulation, provides a downstream functional readout of physiology that integrates genomic, proteomic, and environmental influences. Because urine can be collected non-invasively and repeatedly, it is an attractive medium for tracking these processes in athletes who are tested constantly.

The study’s design reflected the realities of elite sport. Of the 287 samples, 30 were collected during ten clinically confirmed muscle injury and rehabilitation periods from ten distinct players, while the remaining 257 came from healthy periods and served as controls. Injuries were defined and recorded according to UEFA consensus recommendations, diagnosed by the same medical staff throughout, and supported by ultrasound and magnetic resonance imaging when clinically indicated. The injury set spanned the spectrum of lesions common in professional football, including grade 2b and 3c hamstring strains affecting the biceps femoris, semimembranosus, semitendinosus, and rectus femoris muscles. Samples were collected at a median of 22 days post-injury, with the majority drawn during early and late rehabilitation phases rather than the acute window.

On the analytical side, the team used targeted ultra-performance liquid chromatography coupled to tandem mass spectrometry to quantify amino acids and tryptophan-related metabolites. Absolute concentrations were normalized to creatinine to correct for urinary dilution, and tryptophan pathway metabolites were additionally normalized to tryptophan itself, yielding 71 metabolite ratios for statistical analysis. Quality control relied on calibration standards, procedural blanks, retention-time matching, and stable isotope-labeled internal standards added to every sample. Before any supervised modeling, principal component analysis confirmed that injury status was not the dominant source of variance in the dataset, an expected result given that injury-related perturbations are subtle against the broad physiological variability inherent to elite athletes. No analytical outliers or season-related batch effects were detected.

Despite that subtlety, univariate statistics combining Welch’s test, fold-change assessment, and Hedge’s g effect sizes revealed a coherent biochemical story. The most striking signals involved tryptophan metabolism: injured players showed substantially elevated levels of xanthurenic acid, kynurenic acid, and elevated tryptamine-to-tryptophan ratios, alongside higher S-adenosylmethionine. The kynurenine pathway, through which tryptophan is degraded, is strongly regulated by immune signaling and inflammatory mediators and has been widely implicated in exercise-induced adaptation, making its perturbation one of the most biologically relevant responses to muscle damage. Conversely, aminophenol, proline, ornithine, and lysine were reduced in the injury group, consistent with altered protein turnover as the body repools amino acids for tissue repair.

Two further metabolic themes emerged. The first involved purine degradation, particularly hypoxanthine, a well-established marker of energetic stress that accumulates when ATP is broken down faster than it can be regenerated. In the context of muscle injury, elevated hypoxanthine likely reflects both localized energy depletion within damaged fibers and the systemic metabolic cost of sustaining tissue repair. The second theme involved amino acids directly implicated in structural remodeling: proline and ornithine are closely linked to collagen synthesis and connective tissue repair, while elevated beta-aminoisobutyric acid, or BAIBA, has been associated with muscle stress adaptation and mitochondrial remodeling. Changes in alanine, glutamic acid, taurine, beta-alanine, and phenylacetylglutamine reinforced the picture of coordinated protein turnover. Pathway over-representation analysis using the KEGG database pointed to significant enrichment of amino acid metabolic pathways, particularly arginine and proline metabolism, although the authors caution that because the panel was targeted, this enrichment is exploratory rather than definitive mechanistic evidence.

The multivariate analysis was where the findings took on their most clinically suggestive form. Using partial least squares discriminant analysis with leave-one-out cross-validation and 300-fold permutation testing to guard against overfitting, the researchers built a model that separated injured from non-injured samples with a cross-validated area under the receiver operating characteristic curve of 0.88, correctly identifying 73 percent of injury samples and 88 percent of controls, with statistical significance at p less than 0.003. The most influential discriminant metabolites were BAIBA, hypoxanthine, xanthurenic acid, beta-alanine, and alanine, largely consistent with the univariate results. Backward stepwise feature selection then pared the model down to a restricted subset of metabolites that preserved an AUROC of 0.81, a simplification the authors highlight as important for translation, since small targeted panels are more analytically robust and easier to validate in routine clinical settings than full metabolomic profiles.

The team was careful to stress-test its own statistics. Because 30 injury samples came from only ten players, they repeated validation using a stricter leave-one-player-out scheme, under which performance dropped to an AUROC of 0.72. They attribute this decline to the severe class imbalance and the concentration of injury samples among few individuals, and they emphasize that independent player-level validation in larger cohorts is essential before any clinical deployment. The imbalance also shaped other performance metrics: the positive predictive value was a modest 41 percent, while the negative predictive value reached 97 percent, meaning the current score is far better at ruling out injury-related metabolic stress than confirming it. The authors also note that nutritional intake, acute workload, and medication, all of which can influence the urinary metabolome, were not recorded and represent potential confounders.

Perhaps the most visually compelling element of the study is the longitudinal perspective. For eight of the ten injured players, serial samples collected across rehabilitation allowed the researchers to track individual trajectories of a metabolite-based injury score. In a descriptive, exploratory assessment, these trajectories suggested progressive normalization of the metabolic profile during rehabilitation, approaching baseline values by the return-to-play milestone, and players who never sustained injuries showed baseline stability in the score. The study juxtaposes these chemical trajectories with serial 3-Tesla MRI examinations of a 24-year-old player who suffered a complete proximal hamstring aponeurosis tear, documenting the anatomical progression from acute edema and tendon retraction through scar bridging, maturation, and remodeling over eight weeks. The authors argue that macro-structural healing on MRI does not necessarily reflect the resolution of local energetic or systemic inflammatory stress, so mapping metabolomic trajectories against structural lesion evolution could, in principle, reveal whether cellular homeostasis has truly recovered even when imaging looks normal.

The researchers are measured about what their findings can and cannot support. Urinary profiles reflect systemic metabolic balance rather than local tissue remodeling, and the signatures cannot currently be used to guide return-to-play decisions. The observational design limits causal interpretation, and the single-center cohort restricts generalizability. Nevertheless, the demonstration that a coordinated, statistically robust metabolic signature of muscle injury can be captured non-invasively in urine marks a meaningful step toward complementing external load monitoring with an internal readout of biological stress. Future multicenter studies that integrate longitudinal metabolomics with structural imaging, biochemical markers, and clinical assessment will determine whether this multimodal approach adds clinically meaningful value, potentially transforming how the world’s most expensive athletes are monitored, rehabilitated, and returned to competition.

Subject of Research: Urinary metabolomic biomarkers of muscle injury and recovery in professional football players

Article Title: Urinary metabolomic signatures of muscle injury and recovery in elite football players

Article References: Quintás, G., Pruna, R., Wong, M., Mechó, S., Madrero, P., Sanjuán-Herráez, J. D., & Rodas, G. (2026). Urinary metabolomic signatures of muscle injury and recovery in elite football players. Metabolomics, 22(5), Article 158. https://doi.org/10.1007/s11306-026-02530-5

Image Credits: AI Generated

DOI: 10.1007/s11306-026-02530-5

Keywords: metabolomics, muscle injury, football, sports medicine, urine biomarkers, tryptophan metabolism, purine metabolism, PLS-DA, FC Barcelona, athlete monitoring, rehabilitation, UPLC-MS